Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity / Luppi, Mario; Forghieri, Fabio; Potenza, Leonardo. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 71:12(2020), pp. 3265-3266. [10.1093/cid/ciaa323]

Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity

Luppi, Mario;Forghieri, Fabio;Potenza, Leonardo
2020
2020
71
12
3265
3266
WOS:000613755500042
2-s2.0-85088438731
32412056
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity / Luppi, Mario; Forghieri, Fabio; Potenza, Leonardo. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 71:12(2020), pp. 3265-3266. [10.1093/cid/ciaa323]
Luppi, Mario; Forghieri, Fabio; Potenza, Leonardo
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1223461
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact